Medtech Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Diagnostic Imaging buys teleradiology co

This article was originally published in Clinica

Executive Summary

Diagnostic Imaging International (DII), a Las Vegas, Nevada-based operator of diagnostic imaging clinics, is to acquire Canadian Teleradiology Services (CTS), a company specialising in remote site-to-site transmission of medical imaging scans. CTS, founded in 2005, recorded gross revenues of over Can$870,000 (US$707,000) in 2007 from its contract with four public hospitals run by Bluewater Health of Ontario, Canada. Its revenues are expected to grow as the company starts offering teleradiology services to other public hospitals in South Western Ontario. "While teleradiology is a large business in the US that provides a crucial service to the healthcare industry, it is still in its infancy in Canada where CTS is located and is now positioning itself to be a leader in the field," said DII, which has medical imaging clinics in both the US and Canada. The acquisition agreement includes a Can$400,000 upfront payment, as well as an earn-out of three million DII shares, based on CTS' revenue performance for fiscals 2009-11.

You may also be interested in...



Could Alcon's CyPass Trouble Be Boon For Glaukos – Or Bust For MIGS?

Minimally invasive glaucoma surgery specialist Glaukos saw its stock leap 40% in the wake of a worldwide recall by much bigger rival Alcon of its CyPass microstent.

Roche Dx' EMEA Head To Take Charge After Diggelmann Departs

Roland Diggelmann will end his decade-long career at Roche Diagnostics at the end of September. The business's head of EMEA Michael Heuer will take Diggelmann's place while the search is on for his replacement.

Nose For A Good Tech? Philips Adds Nasal Alar Pulse Oximetry To Monitoring Portfolio

Philips has added a new pulse oximetry platform to its patient monitoring portfolio, with the acquisition of Xhale Assurance.

Topics

Latest Headlines
See All
UsernamePublicRestriction

Register

MT043406

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel